UPPSALA, Sweden, Feb. 28, 2002 (PRIMEZONE) -- Personal Chemistry (SSE:PERC) today announced full-year sales of 69.2 million SEK ($6.9 million) for 2001, an increase of 55 million SEK ($5.5 million) from the previous years figure of 14.15 million SEK ($1.4 million). This represents growth in sales of just under 500% for 2001; a significant proportion of which was made in the United States.
"We are very pleased with our increased sales figure for 2001," commented Hans Johansson, CEO. "Personal Chemistry's customer base now includes all top 10 global pharmaceutical companies and 17 out of the top 20." He added, "But there are more than 20,000 medicinal chemists in the pharmaceutical and biotechnology industry alone and we would like to see the vast majority having access to Coherent Synthesis(tm). We have a significant market to aim for."
"Coherent Synthesis is a complete system for chemistry development within medicinal and combinatorial chemistry, integrating knowledge accumulation and automated synthesis. Coherent Synthesis applies diverse technologies such as robotic liquid handling, microwave-assisted chemistry, accessories, chemistry informatics software and proprietary methods to help streamline and improve chemistry development. This unique combination enables chemists to explore, plan, test, perform and document chemical syntheses consistently and reproducibly. Personal Chemistry will announce several new extensions to the product line during 2002.
Personal Chemistry i Uppsala AB is a private Swedish company that develops and markets Coherent Synthesis, a complete solution for faster chemistry development within medicinal and combinatorial chemistry. The company has its headquarters in Uppsala and subsidiaries in Boston (US), Cambridge (UK) and Konstanz (Germany). Personal Chemistry currently employs 100 people of whom more than 40 are chemists. The company was founded Dr Soeren Nygren and financed by HealthCap in 1998. 3i, Investor, Bank Invest and SEB have also invested in Personal Chemistry.
To view this release in its entirety, please click on the link and view the .pdf document: http://reports.huginonline.com/850268/100228.pdf
Please contact Noonan/Russo if you have any problems on +44 20 7726 4452.